Tetanus toxoid is prepared by formaldehyde inactivation of the neurotoxin, tetanus toxin. Formulations containing tetanus toxoid have been used as vaccines to produce immunity to tetanus, the disease caused by C. tetani infection.[1]
Reference:
[1]. Gupta, R.K., and Siber, G.R. Adjuvants for human vaccines--current status, problems and future prospects Vaccine 13(14), 1263-1276 (1995).
















